Derek Maetzold

Title: The Innovative Contributions of Derek Maetzold

Introduction

Derek Maetzold is a notable inventor based in Friendswood, Texas, recognized for his significant contributions to the field of medical diagnostics. With a total of six patents to his name, he has made strides in developing methods that enhance the prediction and treatment of skin cancers.

Latest Patents

One of Derek's latest patents is a diagnostic test for predicting metastasis and recurrence in cutaneous melanoma. This invention encompasses a method for assessing the risk of metastasis of a primary cutaneous melanoma tumor by measuring the gene-expression levels of at least eight genes from a specific gene set. The process involves determining a gene-expression profile signature, comparing it to a predictive training set, and providing an indication of the tumor's class of metastasis or treatment risk based on altered gene expression levels. Another significant patent relates to methods of diagnosing and treating patients with cutaneous squamous cell carcinoma (cSCC). This disclosure focuses on predicting the risk of recurrence and/or metastasis in primary cSCC, thereby improving patient outcomes.

Career Highlights

Derek has worked with prominent organizations such as Castle Biosciences, Incorporated and Indiana University. His experience in these institutions has allowed him to collaborate on innovative projects that push the boundaries of medical research and diagnostics.

Collaborations

Derek has collaborated with notable colleagues, including Robert Willis Cook and Kristen Oeschlager. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Derek Maetzold's work exemplifies the impact of innovation in medical diagnostics, particularly in the realm of skin cancer. His patents not only reflect his expertise but also his commitment to improving patient care through advanced predictive methods.